Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573311 · ClinicalTrials.gov registry record · Phase 3
Actual Use Study of Tamsulosin in Men
A Phase 3 study of Urological Manifestations, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,117
- Enrollment target
- 20
- Study locations
NCT02573311: Completed Phase 3 study of Urological Manifestations, sponsored by Boehringer Ingelheim.
NCT02573311 is a Phase 3 study of Urological Manifestations that has completed, run by Boehringer Ingelheim. The registered enrollment target is 1,117 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02573311, a Phase 3 study of Urological Manifestations, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,117 participants
- Enrollment target
- 20
- Study locations
Study Summary
An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label instructions, also assess any reported adverse events during simulated OTC use.
Primary Outcome
Percentage of men who reported a condition listed under the "Stop use and ask a doctor if" section of the Drug Facts Label (DFL) within the first 12 weeks of using study product and did not stop use or initiated contact with a doctor out of the total population is presented along with 95% exact two sided Clopper-Pearson confidence interval.
Conditions Studied
Interventions
- DRUG tamsulosin hydrochloride
Study Locations (20)
Alabama
- Parkway Discount Drugs - Birmingham
- Homewood Pharmacy - Homewood
- Robert's Discount Pharmacy - Hoover
- Pharmacy at the Pig - McCalla
- Pinson Discount Drugs - Pinson
Minnesota
- Goodrich Pharmacy - Andover
- Goodrich Pharmacy - Blaine
- Goodrich Pharmacy - Elk River
- Northfield Pharmacy - Northfield
- Cub Pharmacy #1924 - Saint Louis Park
Georgia
- Sutton Family Pharmacy - Dalton
- Huff's Drug Store - Ellijay
- Wynn's Pharmacy Incorporated - Griffin
Florida
- Garden Drug - Fort Lauderdale
- Pill Box Pharmacy - Pembroke Pines
Missouri
- The Medicine Shoppe and Elsberry Pharmacy - Elsberry
- Albers' Specialty Pharmacy - Kansas City
Arizona
- ACACIA Apothecary and Wellness - Tucson
California
- Parkview Compounding Pharmacy - Rancho Cucamonga
Illinois
- Family Care Pharmacy - Highland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,117 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2016-08-01 |
| Phase | Phase 3 |
What the finished NCT02573311 record still lists
NCT02573311 is an interventional study that assigns participants to a tested intervention. Its 1,117 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% higher).
The record links to 1 condition, with Urological Manifestations appearing as the primary indexed condition, and to 1 intervention - of which tamsulosin hydrochloride is the first listed.
NCT02573311 names 20 study sites across 8 states, led by Alabama, Minnesota, Georgia.
Frequently Asked Questions
What is clinical trial NCT02573311 about?
NCT02573311 is a clinical study titled "Actual Use Study of Tamsulosin in Men". An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label i...
What is the current status of trial NCT02573311?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,117 participants. The study started on 2015-09-23. Estimated completion is 2016-08-01.
What conditions does trial NCT02573311 study?
This clinical trial studies the following conditions: Urological Manifestations.
What interventions are being tested in trial NCT02573311?
The interventions under investigation include: tamsulosin hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02573311?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02573311 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urological Manifestations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02573311's enrollment target sits among peer trials
1,117 251st of 2000 higher than 1,750 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI